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Objectives. This review sought to determine whether passive
smoking in the workplace has roughly the same association with
heart disease as passive smoking at home and to update a
previous 1994 review on the effects of home-based passive expo-
sure on the heart.
Background. To predict the effects of passive smoking at work
on heart disease, public agencies have had to assume that
workplace exposure to tobacco smoke was equivalent to home
exposure. With the availability of more workplace exposure data,
it is now possible to make a direct comparison.
Methods. The odds ratios and relative risks (RRs) of the eight
studies that contained data on workplace exposure (1,699 cases)
were arranged in what was believed to be the order of the quality
of their tobacco smoke exposure measurements. A meta-analysis
was performed to obtain combined RRs. Data from seven new
studies on largely home-based exposure and heart disease that
were not included in the 1994 review were also evaluated.
Results. The combined RR for the three top-rated workplace
studies was 1.50 (95% confidence interval [CI] 1.12 to 2.01).
Adding four lower rated studies reduced the RR to 1.35 (95% CI
1.09 to 1.67). Adding the largest study but the one with question-
able exposure history reduced the combined RR to 1.18 (95% CI
1.04 to 1.34). Adding the seven new, largely home-based studies
increased the home-based morbidity RR to 1.49 (95% CI 1.29 to
1.72) compared with 1.42 in 1994 while leaving the mortality RR
unchanged at 1.23 (95% CI 1.14 to 1.32).
Conclusions. The RRs for heart disease from passive smoking
at work are roughly equal to those from home-based exposure.
(J Am Coll Cardiol 1998;31:1–9)
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There have been several reviews of the effects on heart disease
of exposure to environmental tobacco smoke (ETS), either
from spousal smoking or from the smoke of others (1–7), but
there has been no published overall review of epidemiologic
studies of the effects of workplace exposure on heart disease.
The effects on heart disease of exposure to ETS at the
workplace are important, not only for public policy reasons,
but because the results are less likely to be subject to potential
confounding from lifestyle factors that might affect home-
based results. Since my previous review in 1994 (1), seven new
studies (8–14) of passive smoking and heart disease have
appeared, four of which (9,10,12,13) contain data on work-
place exposure and are included in the present analysis. An
update of the 1994 review (1) of heart disease and exposure to
ETS for all types of exposures and including the new studies is
presented in the Appendix.
Methods
All known published studies that contained data on heart
disease and exposure to ETS at the workplace were considered
for inclusion. Workplace results based on .50% surrogate
responses were rejected because it is thought that surrogates
do not have sufficiently accurate recall of a subject’s likely
workplace exposure. The only workplace results excluded from
the present analysis are those of Jackson (15) for cardiac
death, where 100% of the case responses were from surrogates.
In general, where two or more workplace risks were available
from a particular study, the risk was chosen for exposure with
or without other ETS exposure. In other words, the workplace
exposure was looked on as an added exposure to whatever else
the subject had been exposed to. Also, the risk was chosen for
which the maximal number of adjustment factors had been
used and which was thought to have the least tendency for
exposure misclassification.
Odds ratios (ORs) from case-control studies were assumed
to be reasonable approximations to relative risks (RRs) be-
cause most of the case-control studies met the criteria of
Breslau and Day (16), except for Muscat et al. (12), where data
were collected over a 10-year period. Combined RRs were
obtained by calculating weighted log means of the ORs or RRs
from any appropriate group of studies. According to Rothman
(17), the statistical weight for any specific ln(OR) or ln(RR)
was assumed to be the inverse of its variance (or standard
deviation squared), which in turn was usually calculated from
the individual confidence limits (CLs) of the 95% confidence
interval (CI) [Weight 5 (2 3 1.96)2/(ln CLupper 2 ln CLlower)
2]
or, when necessary, from chi-values developed from the cell
counts [Weight 5 (Chi/ln RR)2]. For some of the studies, ORs
or RRs plus CIs were available only for two or three different
levels of exposure. To arrive at a single OR or RR and weight
in these instances, the weights calculated for the individual
exposure levels were summed, but because this involved mul-
tiple use of the no-exposure level, the sum was reduced by a
fraction that was determined from other studies (10,18,19 and
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CIs for both individual levels and the combined exposure were
known, and the corresponding weights could be determined. It
was found that the reductions were a function of the fraction of
the control subjects who were unexposed. For two levels of
exposure, the reductions varied from 12% for 80% unexposed
to 45% for 20% unexposed. For three levels, the reductions
were slightly higher. No attempt has been made to correct the
risks for smoker misclassification. This correction was found to
be small in the earlier review (1). The correction depends on
the tendency for smokers to marry smokers, which does not
apply to the workplace, and the correction cannot be estimated
for some of the new studies in which the mix of male and
female subjects is not provided.
In the earlier review (1), studies were assigned a quality tier
level related to the number of other heart disease risk factors
that had been used to adjust the OR or RR because possible
confounding by lifestyle factors was a concern relative to the
largely home-based risks. For workplace risks there is greater
concern about possible errors in measuring the level of expo-
sure than there is about possible confounding by lifestyle
factors. Factors that were thought to influence the quality of
the studies were passive smoking history, prevalence of current
smokers (of the same gender as the subjects) in the population,
whether the subjects in the reference category included only
those employed, years of follow-up for the prospective studies,
time span for collection of data for the case-control studies and
adjustment for other heart disease risk factors. Using these
factors, with special emphasis on the history of passive smoking
exposure, tier levels one (highest quality) through four were
assigned to the workplace studies, which were then arranged in
that order in the tables.
Results
Descriptions of the individual studies containing data for
heart disease and workplace exposure to ETS are shown in
Table 1. The RRs for the individual studies and the combined
RRs are shown in Table 2. The top-rated study in Table 1 is
that of He et al. (9) who studied women in Xian, China. It
focused primarily on workplace effects, with an excellent
history of workplace exposure, including the number of
cigarettes/day smoked by co-workers, duration of exposure in
years, number of co-workers who smoked and daily exposure
time in hours. Passive smoking was defined as working with
co-workers who smoked in the same unit for .5 years.
Smoking prevalence among women in Xian is only 8.6%,
whereas most men smoke. However, because of the Oriental
culture, other than their husbands and possibly other male
relatives, nonsmoking women would be exposed to very few
men outside the workplace. Therefore, the background effects
of ETS should be minimal. All the women studied were
full-time employees. The possible confounding effect of other
heart risk factors was thoroughly evaluated.
The next study presented in Table 1 is that by Kawachi et al.
(10) from the well known Nurses’ Health Study, which has
been conducted over many years by Harvard Medical School
and the Harvard School of Public Health. Passive smoking was
defined as current exposure to cigarette smoking at work but
was measured only at enrollment in 1982. This study provides
two levels of ETS exposure (occasional and regular) and
adjusts for a large number of heart disease risk factors.
The study by Butler (18) is a published doctoral disserta-
tion. Subjects were asked whether they had worked in the same
room with someone who smoked and, if so, for how many
years? There were a small number of long-term ex-smokers
included among the nonsmokers in the cohort, but it was
expected that they would have little effect on the workplace
passive smoking RR. The cohort consisted of Seventh Day
Adventists, who are proscribed from smoking by church rules.
Current smoking prevalence was 2.1% among the men and
1.1% among the women, indicating low background effects of
ETS. However, the RRs were adjusted only for age.
There is little to choose from among the next four studies
(12,15,20,21). None reported any passive smoking history other
than exposed or not exposed, nor were many heart risk factors
considered other than age. The cohort for the study by
Svendsen et al. (20) consisted of men at high risk for heart
disease. Subjects were asked whether most of their co-workers
smoked. The study by Jackson (15) was published only as a
doctoral dissertation. Subjects exposed to ETS during tea
breaks were included among the nonexposed. The study by
Muscat and Wynder (12) was conducted in four hospitals in the
northern United States. They apparently measured years of
exposure but reported only current exposure. The study by
Dobson et al. (21) may be the weakest of the studies. It
provides no breakdown for surrogate versus direct interviews,
no information on the proportion of fatal versus nonfatal cases
and no definition of passive smoking.
Because of its very large size, The American Cancer Society
study analyzed by Steenland et al. (13) is shown separately so
that its results can be compared with the combined results of
all the other studies. Its questionnaire (personal communica-
tion, American Cancer Society, 1981) was administered by
American Cancer Society volunteers. It had only a single,
simple passive smoking question, namely, “Whether or not you
smoke, on the average, how many hours a day are you exposed
to cigarette smoke of others: At home__, At work__, In other
areas__.” Many of the never-smoking respondents failed to
answer these questions and were excluded from the analysis.
Specifically, 28.2% of men and 48.4% of women failed to
answer the workplace question, whereas some respondents
Abbreviations and Acronyms
CHD 5 coronary heart disease
CI 5 confidence interval
CL 5 confidence limit
ETS 5 environmental tobacco smoke
OR 5 odds ratio
RR 5 relative risk
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Table 1. Epidemiologic Studies of Heart Disease and Passive Smoking in the Workplace
Study (ref no.) Locale
Study
Type
Population
Fatal or
Nonfatal
Passive
Smoking
History
Current
Smokers
[% (M/F)]
Ref
Category:
Workers
Only
Follow-Up
(yr) (pros)
Data
Collection
(yr) (C/C) Other Adjustment Factors
Quality
Tier
Assigned*
No. of Cases
No. of Control
Subjects
M F M F
He et al. (9) China C/C — 59 — 126 nf d, c, n, h 8.6 Yes — 3 A, B, C, D, FH, FIHD, E,
HC, MS, O, P, S, W, X
1
Kawachi et al. (10) USA Pros — 64 — 32,046† nf o, r 29 ? 10 — A, AL, AS, B, C, CA, D, ES,
FIHD, FO, FT, MI, MN,
OC, ST, VE, W, X
2
Butler (18) Calif Pros 75 70 2,345 4,122 f d 2.1/1.1 No 6 — A 3
Svendsen et al. (20) USA Pros 69‡ — 1,237 — f1nf — 72 Yes 8 — A 4
Jackson (15)§ NZ C/C 28 8 114 97 nf — 20/24 No? — 2 A, MI, SS 4
Muscat and Wynder (12) No. USA C/C 68 35 108 50 nf — ? Yes — 10 A, B, E 4
Dobson et al. (21) Australia C/C 75 17 205 197 f1nf — 25/16 Yes — 1.4 A, MI 4
Subtotal 335 277
Steenland et al. (13)\ USA Pros 768 319 75,237 108,302 f — 29/24 Yes 7 — A, AL, AR, AS, B, D, DU, E,
ES, MI, W, X
—
Total 1,103 596
*Tier 1 is highest quality; tier assignment is based primarily on quality of passive smoking history, secondarily on the other factors in the table. High smoking prevalence is adverse because of high environmental tobacco
smoke background; a reference category of workers only is favorable; and shorter years of follow-up or data collection are favorable. †Includes nonemployed women. ‡Includes 13 fatal cases. §Jackson (personal communication,
1993) advises that some of these cases and control subjects were later found to be ineligible, but the odds ratios are correct. \Cases and populations include workers .65 years old. A 5 age; AL 5 alcohol use; AR 5 arthritis;
AS 5 aspirin use; B 5 blood pressure or hypertension; c 5 cigarettes/day; C 5 cholesterol; CA 5 cancer; Calif 5 California; C/C 5 case-control; d 5 duration (yr); D 5 diabetes; DU 5 diuretic drug use; E 5 education;
ES 5 estrogen use; f 5 fatal; F 5 female; FH 5 family history of hypertension; FIHD 5 family history of ischemic heart disease; FO 5 father’s occupation when subject was age 16; FT 5 saturated fat intake; h 5 hours/day;
HC 5 high density cholesterol; HSM 5 husband’s smoking; M 5 male; MI 5 personal history of myocardial infarction; MN 5 menopausal status; MS 5 marital status; n 5 number of smokers; nf 5 nonfatal; No. 5 northern;
NZ 5 New Zealand; o 5 occasional exposure; O 5 occupation; OC 5 oral contraceptive use; P 5 personality type; Pros 5 prospective; r 5 regular exposure; ref 5 reference; S 5 stress; SS 5 social status; ST 5 stroke;
VE 5 vitamin E intake; W 5 weight or body mass index; X 5 exercise; — 5 not applicable or no data.
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used only a checkmark. No analysis of intensity of exposure at
work is given. The workplace RR chosen here is for workers
,65 years old because most of the workers .65 years old
would have retired during the 7-year follow-up period and
would no longer have been exposed to ETS at work. Although
very large, and therefore having high statistical weight, and
having adjusted for a number of heart disease risk factors, the
American Cancer Society study, as a workplace study, leaves
much to be desired in terms of the quality of its exposure data.
No formal tier level was assigned to this study.
The combined RR for the studies by He et al. (9) and
Kawachi et al. (10), probably the two best studies, is 1.76 (95%
CI 1.04 to 2.98). Inclusion of the results from Butler (18)
reduces the combined RR for both men and women to 1.50
(95% CI 1.12 to 2.01). Adding the other four studies (except
Steenland et al. [13]) approximately doubles the statistical
weight from 44.4 to 86.1 but reduces the combined RR to 1.35
(95% CI 1.09 to 1.67). Inclusion of the study by Steenland et al.
(13), with its total weight of 157.6 and questionable exposure
history, nearly triples the statistical weight but reduces the
combined RR to 1.18 (95% CI 1.04 to 1.34).
With regard to dose response only, He et al. (9) and Butler
(18) provide data for duration of exposure, and there is no
evidence that longer exposure is associated with a higher risk
than shorter exposure. For intensity of exposure, we have data
from both He et al. (9) and Kawachi et al. (10). Here, a strong
effect of higher risk with higher dose is observed. The morbid-
ity and mortality RR values (Table 2) are higher for women
than for men. The morbidity RR values for workplace expo-
sure are higher than those for mortality, which is consistent
Table 2. Odds Ratios and Relative Risks for Heart Disease and Passive Smoking in the Workplace
Study (ref no.)
Adjusted OR or
RR (95% CI)
Statistical
Weight
Dose Response
Intensity Duration
He et al. (9) 1.85 (0.86–4.00) 6.5 0.87, 2.95, 3.56*, 1.16, 5.06,
4.11‡, 0.62, 4.03, 21.32§
3.08, 1.56†
Kawachi et al. (10) 1.68 (0.81–3.47) 7.3 1.49, 1.92\
Butler (18)
Men 1.02 (0.61–1.70) 14.6 — 1.26, 0.76¶
Women 1.85 (1.13–3.02) 16.0 — 1.85, 1.86¶
Svendsen et al. (20) 1.4 (0.8–2.5) 11.8 — —
Jackson (15)
Men 1.8 (0.8–4.3) 5.1 — —
Women 1.1 (0.2–5.8) 1.4 — —
Muscat and Wynder (12)
Men 1.2 (0.6–2.2) 9.2 — —
Women 1.0 (0.4–2.5) 4.6 — —
Dobson et al. (21)
Men 0.95 (0.51–1.78) 7.5 — —
Women 0.66 (0.17–2.62) 2.1 — —
Subtotal
Men 1.19 (0.90–1.58) 48.2
Women 1.58 (1.15–2.17) 37.9
Both 1.35 (1.09–1.67) 86.1
Steenland et al. (13)
Men 1.10 (0.82–1.31) 123.1 — —
Women 1.09 (0.78–1.52) 34.5 — —
Morbidity1Mortality Morbidity Mortality
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Total
Men 1.13 (0.97–1.31) 171.3 1.28 (0.91–1.79) 33.6 1.09 (0.92–1.29) 137.7
Women 1.32 (1.05–1.66) 72.4 1.38 (0.91–2.10) 21.9 1.29 (0.98–1.70) 50.5
Both 1.18 (1.04–1.34) 235.6 1.32 (1.01–1.72) 55.5 1.14 (0.99–1.32) 188.2
*Six to 10, 11 to 20, 201 cigarettes/day smoked by co-workers (p 5 0.022 for trend). †Six to 15, 161 years of exposure
(p 5 0.12 for trend). ‡One to two, three, four or more smokers (p 5 0.024 for trend). §One to 2, 3 to 4, 51 h/day of
exposure (p 5 0.002 for trend). \Occasional, regular exposure. ¶One to 10, 111 years of exposure. CI 5 confidence
interval; OR 5 odds ratio; ref 5 reference; RR 5 relative risk; — 5 no data.
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with the largely home-based results (see Appendix, Tables A2
and A3).
Discussion
As noted, the quality of some of the workplace studies is
marginal at best. Recall bias may not be a serious problem
because no surrogate responders were used, except for some of
the fatal cases in Dobson et al. (21). Trained interviewers were
used for most of the studies, although Kawachi et al. (10) relied
on mailed questionnaires, and, as noted, Steenland et al. (13)
used American Chemical Society volunteers. Repeatability of
workplace exposure estimates has been investigated by Pron et
al. (22) indicating that repeatability for female never-smokers
is about the same for occupational and residential exposure,
but the comparison is less good for men, which may be
reflected in the lower combined workplace RR for men than
for women. Alternatively, their lower RR may be due to
chance because in the largely home-based exposure RRs in the
Appendix, the gender results are mixed. Not all the studies
adjusted for the same heart risk factors, but where crude and
adjusted RRs were given, they were not radically different.
Also, the adjustments tended to offset each other in the
combined RRs because adjustments in some of the studies
increased RRs, whereas in others they were reduced.
Taking all seven studies together, there is evidence that
exposure to ETS at the workplace is associated with heart
disease and that the combined RRs are statistically significant.
The combined RRs for studies with the better workplace
exposure histories (9,10,18) are similar to the combined RRs
from the better studies of total residential exposure, as shown
in the Appendix (Tables A2 and A3). This similarity is
supported by the observation in the 1992 Environmental
Protection Agency (EPA) report (23) that, on the basis of
ambient nicotine measurements, workplace and residential
exposures to ETS are similar. It is also evident that the studies
with better workplace ETS exposure histories (9,10,18) have
higher RRs than those with poorer histories (12,13,15,20,21).
Thus, the workplace data relating passive smoking to heart
disease support the studies based on home-based exposure and
indicate that using the home-based RRs to predict workplace
effects is probably valid.
Appendix
Update of the 1994 Review of Heart Disease From
Exposure at Home to Environmental
Tobacco Smoke
Seven studies of passive smoking and heart disease (8–14) that have
recently appeared were not included in the 1994 review (1) on that
subject. Brief descriptions of the new studies, similar to those in Table
1 of Wells (1), are presented in Table A1. As before, the studies are
assigned to quality tier levels on the basis of the numbers of other heart
disease risk factors for which the investigators made adjustments. The
study by He et al. (9) emphasizes workplace exposure but also includes
data on spousal exposure and combined exposure from spouse and at
work. The study by Tunstall-Pedoe et al. (14) reports an association
between heart disease and exposure to “tobacco smoke from someone
else in the last three days.” They report exposure on the basis of
self-report and serum cotinine levels, both for diagnosed and undiag-
nosed coronary heart disease (CHD). I chose the odds ratio based on
serum cotinine data for diagnosed CHD as the most relevant. The
large study by Steenland et al. (13) is much better for spousal exposure
than for workplace exposure because they had matching data on
spousal smoking habits provided by the spouses themselves, which
gives a measure of duration of exposure that was absent from the
workplace data. Steenland et al. (13) found very little risk for exposure
to ex-smoker compared with current-smoker spouses. For the present
analysis I chose their relative risks (RRs) where both spouses con-
firmed each other’s smoking status because these data would be least
Table A1. Recent Studies of Passive Smoking and Ischemic Heart Disease Among Never-Smokers Not Included in 1994 Review*
Study (ref no.) Locale
Time
Frame
Study
Type
No. of
Cases
Population or
Control
Subjects
End
Point
Fatal
or
Nonfatal Adjustment Factors
Quality
Tier
Assigned†F M F M
Ciruzzi et al. (8) Argentina 1991–1994 C/C 336 446 AMI nf A, B, C, D, E, FIHD, SX, W 1
He et al. (9)‡ China 1989–1992 C/C 59 — 126 — CHD nf See Table 1 1
Kawachi et al. (10) USA 1982–1992 Pros 25 — 32,046 — CHD f See Table 1 1
152 — 32,046 — CHD nf See Table 1 1
La Vecchia et al. (11) Italy 1988–1989 C/C 44 69 60 125 AMI nf A, B, C, CF, D, E, FIHD, SX, W 1
Muscat and Wynder (12) USA 1980–1990 C/C 46 68 50 108 MI nf See Table 1 3
Steenland et al. (13) USA 1982–1989 Pros 426 1,180 80,549 54,668 CHD f See Table 1 1
Tunstall-Pedoe et al. (14) Scotland 1984–1986 CS 70 2,278 CHD nf A, B, C, HT 3
*Wells (1). †Tier 1 studies were adjusted for six of the following or five plus two others: age, hypertension, cholesterol, weight, social class, marital status, personal
history of heart disease, exercise and history of diabetes; tier 2 studies for four of the above or three plus two others; tier 3 studies for two of the above or one plus
two others; tier 4 studies for fewer than tier 3. ‡Replaces earlier report, which was reference 31 in Wells (1). A 5 age; AMI 5 acute myocardial infarction; B 5 blood
pressure or hypertension; C 5 cholesterol; C/C 5 case control; CHD 5 coronary heart disease; CS 5 cross sectional; D 5 diabetes; E 5 education; f 5 fatal; F 5
female; FIHD 5 family history of heart disease; HT 5 housing tenure; M 5 male; MI 5 myocardial infarction; nf 5 nonfatal; Pros 5 prospective; ref 5 reference;
SX 5 gender; — 5 not applicable.
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subject to exposure misclassification (Steenland et al. [13], Table 5).
Although this data set provides RRs for exposure to currently smoking
spouses only, it should cover most of the passive smoking effects.
Tables 2 and 3 from the 1994 review (1) covered morbidity and
mortality RRs, respectively, for passive smoking and heart disease.
They have been revised to include the new studies and are shown as
Tables A2 and A3. The revised tables classify exposure into all-adult,
total home and spouse-only exposure. This classification was done to
show that, as many suspect, spousal exposure is a weak measure for
determining passive smoking effect, probably because of the large
background effects of environmental tobacco smoke (ETS) in Western
developed countries. Except for the effects of the result of Dobson et
al. (21) on the combined male morbidity RR for home exposure and
the result of Jackson (15) on the combined male mortality RR for all
exposures, the RRs for both the individual studies and the combina-
tions shown in Tables A2 and A3 increase as the breadth of exposure
expands from spouse only to total home to all exposures. If one uses
the OR or RR for the broadest exposure available for each study, the
combined male plus female RR for all studies is 1.49 (95% CI 1.29 to
1.72) for morbidity and 1.23 (95% CI 1.14 to 1.32) for mortality. For
Table A2. Studies Associating Ischemic Heart Disease Morbidity With Passive Smoking
Study (ref no.)
Exposure
Dose Response
Quality
Tier
All Adult Home Only Spouse Only
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Adjusted OR
or RR
(95% CI)
Statistical
Weight Intensity Duration
Ciruzzi et al. (8)
M1F — 1.66 (1.2–2.3) 36.3 1.43 (0.9–2.3)* 17.5 1.27, 2.41† — 1
He et al. (24)
F — — 1.50 (0.63–3.6) 5.1 — — 1
He et al. (9)
F 2.36 (1.01–5.55) 5.3 — 1.24 (0.56–2.72) 6.2 1.75, 3.11,
7.61‡
— 1
Kawachi et al. (10)§
F 1.71 (1.03–2.84) 14.9 1.53 (0.81–2.90) 9.4 — 1.19, 2.11\ 0.91, 1.54, 1.11, 1.50¶ 1
La Vecchia et al. (11)
M1F — — 1.08 (0.58–2.01) 9.9 0.91, 1.21#
1.13, 1.30** — 1
Svendsen et al. (20)§
M — — 1.61 (0.96–2.71) 14.3 1.2, 1.75†† — 1
Hole et al. (25)
M1F — 1.13 (0.77–1.66) 25.6 — 1.3, 1.6‡‡ — 2
Dobson et al. (21)§
M — 0.97 (0.50–1.86) 8.9 — — — 3
F — 2.46 (1.47–4.13) 14.4 — — — 3
Jackson (15)
M 2.7 (0.6–12.1) 1.7 1.03 (0.27–3.9) 2.2 — — — 3
F 4.4 (0.4–49.5) 0.7 2.7 (0.57–12.3) 1.6 — — — 3
Lee et al. (26)
M — — 1.24 (0.59–2.59) 7.1 — — 3
F — — 0.93 (0.54–1.62) 12.6 — — 3
Muscat and Wynder (12)§§
M1F 1.5 (0.9–2.6) 13.7 — — — No trend 3
Tunstall-Pedoe et al. (14)
M1F 1.9 (1.1–3.3) 11.9 — — 1.5, 1.7, 2.7\ \ 3
M, combined 2.7 (0.6–12.1) 1.7 0.98 (0.54–1.76) 11.1 1.47 (0.96–2.25) 21.4
F, combined 1.92 (1.25–2.95) 20.9 2.08 (1.41–3.07) 25.4 1.11 (0.74–1.66) 23.4
M1F 1.80 (1.36–2.39) 48.2 1.50 (1.23–1.83) 98.4 1.28 (1.02–1.61) 72.7
M1F, tier 1 only 1.86 (1.20–2.88) 20.2 1.63 (1.22–2.18) 45.7 1.39 (1.06–1.82) 53.0
M1F, all studies, broadest
exposure for each
1.49 (1.29–1.78) 182.4
*Upper confidence limit increased by the present author from 2, as published in Ciruzzi et al. (3), to 2.3 to be consistent with lower confidence limit and point
estimate in the report. †One to 20, 201 cigarettes/day by spouse. ‡Low, moderate, high total exposure (cigarettes/day 3 years). \Occasional, regular exposure at home.
§Includes some fatal cases (see Table 1, present report, or Table 1, Wells [1]). ¶One to 9, 10 to 19, 20 to 29, 301 years of home exposure. #Ex-smoker, current smoker.
**Less than 15, 151 cigarettes/day. ††One to 19, 201 cigarettes/day. ‡‡Less than 15, 151 cigarettes/day (females only). §§Separate adjusted odds ratios (OR) for males
(M) and females (F) can be estimated by combining ORs for each of three levels of exposure duration and are 1.4 for males and 1.5 for females; there is no evidence
of trend for longer versus shorter exposure. \ \Little, some, a lot of exposure (cotinine groups). CI 5 confidence interval; ref 5 reference; RR 5 relative risk; — 5
no data.
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morbidity and mortality combined, the RR is 1.28 (95% CI 1.20 to
1.37).
The classification scheme used has five of the seven new studies
(8–11,13) as tier 1 in quality, meaning that they adjusted for a large
number of heart risk factors. Also, five of the seven studies report RRs
$1.5, increasing the confidence that the observed effect is real and not
the effect of some as yet undiscovered source of confounding. Two
studies related to the tobacco industry have not been included. The
analysis of the American Cancer Society data by LeVois and Layard
(32) was rejected as vague as to which subjects were included and
which excluded. It has been superceded by the more detailed analysis
by Steenland et al. (13) of much of the same data set. Also rejected was
the study by Layard (33) of a 1% sample of U.S. deaths from the 1986
National Mortality Followback Survey (NMFS). The sample was
heavily overweighted in blacks, Native Americans, young persons and
young persons who had died of ischemic heart disease (34). A mailed
questionnaire was used. Because the subjects were already dead, their
smoking status and lifestyle characteristics were determined 100% by
surrogates. ETS exposure was from spouses only, and 65% of their
smoking status was determined by surrogates, in contrast to the larger
Table A3. Studies Associating Ischemic Heart Disease Mortality With Passive Smoking
Study (ref no.)
Exposure
Dose
Response
Quality
Tier
All Adult Home Only Spouse Only
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Adjusted OR
or RR
(95% CI)
Statistical
Weight
Adjusted OR
or RR
(95% CI)
Statistical
Weight Intensity Duration
Garland et al. (27)
F — — 2.7 (0.7–10.5) 2.1 3.0, 2.25* — 1
Kawachi et al. (10)
F 1.87 (0.56–6.20) 2.1 — — 1.50, 2.55† — 1
Steenland et al. (13)‡
M — — 1.23 (1.03–1.47) 121.5 1.37, 1.15,
1.12§
1.14, 1.13,
1.14, 1.25\
1
F — — 1.19 (0.97–1.45) 95.1 1.22, 1.14,
1.02, 1.28¶
0.84, 0.99,
1.20, 1.20\
1
Svendsen et al. (20)
M — — 2.23 (0.72–6.92) 3.0 0.90, 3.21# 1
Hole et al. (25)
M — 1.73 (1.01–2.96) 13.3** — 2
F — 1.65 (0.79–3.46) 7.0** — 2.09, 4.12†† 2
Humble et al. (28)‡
F — — 1.59 (0.99–2.57) 16.9 1.02, 2.11,
2.55‡‡§§
p 5 0.09 for
trend§§
2
Jackson (15)
M 1.1 (0.23–5.2) 1.6 0.6 (0.06–5.9) 0.7 — 3
F 5.8 (0.95–35.2) 1.2 23.5 (2.8–199) 0.8 — 3
Sandler et al. (29)
M — 1.31 (1.05–1.64) 77.3 — 1.38, 1.25\ \ 3
F — 1.19 (1.04–1.36) 213.5 — 1.20, 1.27\ \ 3
Butler (18)¶¶
M — — 0.55 (0.29–1.04) 9.6 — 0.41, 0.61††† 4
F — — 1.28 (0.90–1.81)## 31.9## — 1.46, 1.53††† 4
Hirayama (30)
F — — 1.15 (0.93–1.42) 85.8 1.08, 1.30‡‡‡ 4
M, combined 1.1 (0.23–5.2) 1.6 1.36 (1.10–1.66) 91.3 1.18 (1.00–1.40) 134.3
F, combined 2.82 (0.95–8.3) 3.3 1.22 (1.07–1.39) 221.3 1.22 (1.07–1.40) 208.8
M1F 2.08 (0.86–5.03) 4.9 1.25 (1.12–1.40) 312.6 1.21 (1.09–1.35) 342.9
M1F, tier 1 only 1.87 (0.56–6.20) 2.1 — 1.23 (1.08–1.40) 221.7
M1F, all studies,
broadest exposure
for each
1.23 (1.14–1.32) 681.9
*Ex-smokers, current smokers. †Occasional, regular exposure. ‡Exposure to currently smoking spouses only. §Cigarettes/day: ,20, 20, .20. \For males (M): 1–12,
13–21, 22–29, 301 years; for females (F): 1–14, 15–25, 26–33, 341 years. ¶Cigarettes/day: ,20, 20, 21–39, 401. #Cigarettes/day: 1–19, 201. **Relative risk (RR) values
updated through 1988 by Hole DJ, personal communication, January 1990. ††Cigarettes/day: ,15, 151. ‡‡Cigarettes/day: ,10, 10–20, .20. §§For high social status
whites only. \ \Cigarettes/day: ,10, 101; from related paper, Helsing et al. (31): Cigarettes/day approximated on the basis of exposure scores. ¶¶Exposure from a few
nonspouse household members but mostly from spouses. ##For female subjects, Butler (18) provided data for two partly overlapping cohorts: 11,660 spouse pairs (80 deaths)
and 4,122 female subjects from the Adventist Health Smog Study (AHSMOG) (70 deaths). The values shown are estimated for a combination of the spouse pairs and
AHSMOG cohorts. The data for male subjects are from the AHSMOG cohort only. †††One to 10, 111 years. ###Cigarettes/day: ex-smoker plus 1–19, 201. Other
abbreviations as in Table A2.
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mortality studies in Table A3, where the smoking status of the subjects,
their spouses and other household members all came from direct
interviews. The ETS exposure in Layard (33) was from any spouse who
smoked .100 cigarettes in total at anytime during the various mar-
riages, so that it would have included exposure from ex-smokers who
had quit a long time ago or current smokers, some of whom would
have been occasional or light smokers. With the high proportion of
surrogate responses, there is often confusion between those subjects
who are reported as unexposed and those who are reported as lightly
exposed. In the light of all these difficulties, it was decided to reject the
study by Layard (33).
Neither LeVois and Layard (32) or Layard (33) found any associ-
ation between passive smoking and heart disease. However, if one
assumes that there might have been confusion between the reported
lightly exposed subjects in the study by Layard (33) and the reported
unexposed subjects, and if the two groups had been lumped together as
a combined reference category, the OR for the more heavily exposed
subjects would have been raised to about the 1.15 level. Even if the
results of Layard had been included as is, the combined RR for
broadest exposure for mortality would have been reduced from the
1.23 RR noted above to 1.17 (95% CI 1.10 to 1.25) and for mortality
and morbidity combined, from 1.28 to 1.22 (95% CI 1.15 to 1.29).
In the 1994 review (1) probable deaths from passive smoking and
heart disease were calculated on the basis of the combined RR for men
plus women for those U.S. studies that were classed as tier 3 or better.
The combined RR was 1.25 (95% CI 1.12 to 1.40) before correction for
smoker misclassification and 1.22 after such correction. The “home
only” or “spouse only” columns in Table A3 are probably the closest to
the exposure that was used in 1994. They now include the studies by
Kawachi et al. (10) and Steenland et al. (13) and some correction to
the statistical weights of Butler et al. (18). The combined male plus
female RR for the U.S. studies classified as tier 3 or better is still 1.25
(95% CI 1.15 to 1.36), the same as before but with a slightly tighter CI.
Therefore, the death estimates from the 1994 review (1) remain
essentially unchanged.
With respect to dose response, many of the studies show increases
in heart disease risk with increasing intensity of exposure, but the data
on duration of exposure are not consistent with respect to trend. Most
of the studies show increased risks relative to no exposure, but the risks
from longer exposure are not consistently higher than the risks from
shorter exposure. Only the data of Steenland et al. (13) show a weak
positive trend with increased duration of exposure for both men and
women. Also, most of the studies that provide data on exposure to
ex-smokers as well as current smokers indicate that exposure to
current smokers results in higher risks. Overall, these results are
consistent with the concept (6) that heart disease risks from cigarette
smoke are a combination of short- and long-term effects.
The biologic plausibility of heart disease from passive smoking has
been dealt with at length by Glantz and Parmley (3,6) in their reviews
and in their recent editorial (7). In brief, acute exposure to ETS has a
negative short-term effect on the ability of the heart to receive and
process oxygen; it activates platelets in the blood, causing them to
become stickier; and it enhances their ability to damage the lining of
the coronary arteries. Longer term effects from chronic exposure
include the acceleration of plaque formation in the arteries. The new
epidemiologic evidence for an association of increased heart disease
risk with ETS exposure reinforces what was available in 1994 and is
consistent with the biologic evidence that ETS has short-term as well
as long-term adverse effects on the cardiovascular system. This in turn
suggests that the effect is causal.
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